These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38663106)

  • 1. Helminth-derived molecules improve 5-fluorouracil treatment on experimental colon tumorigenesis.
    Mendoza-Rodríguez MG; Medina-Reyes D; Sánchez-Barrera CA; Fernández-Muñoz KV; García-Castillo V; Ledesma-Torres JL; González-González MI; Reyes JL; Pérez-Plascencia C; Rodríguez-Sosa M; Vaca-Paniagua F; Meraz MA; Terrazas LI
    Biomed Pharmacother; 2024 Jun; 175():116628. PubMed ID: 38663106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helminth-derived molecules inhibit colitis-associated colon cancer development through NF-κB and STAT3 regulation.
    Callejas BE; Mendoza-Rodríguez MG; Villamar-Cruz O; Reyes-Martínez S; Sánchez-Barrera CA; Rodríguez-Sosa M; Delgado-Buenrostro NL; Martínez-Saucedo D; Chirino YI; León-Cabrera SA; Pérez-Plasencia C; Vaca-Paniagua F; Arias-Romero LE; Terrazas LI
    Int J Cancer; 2019 Dec; 145(11):3126-3139. PubMed ID: 31407335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis.
    Mendoza-Rodríguez MG; Sánchez-Barrera CÁ; Callejas BE; García-Castillo V; Beristain-Terrazas DL; Delgado-Buenrostro NL; Chirino YI; León-Cabrera SA; Rodríguez-Sosa M; Gutierrez-Cirlos EB; Pérez-Plasencia C; Vaca-Paniagua F; Meraz-Ríos MA; Terrazas LI
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
    Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
    Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway.
    Hong S; Cai W; Huang Z; Wang Y; Mi X; Huang Y; Lin Z; Chen X
    Oncol Rep; 2020 Oct; 44(4):1333-1342. PubMed ID: 32945504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancer.
    Yaghoubi A; Asgharzadeh F; Movaqar A; Ghazvini K; Hassanian SM; Avan A; Khazaei M; Soleimanpour S
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2851-2865. PubMed ID: 34117917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic therapeutic effects of Schiff's base cross-linked injectable hydrogels for local co-delivery of metformin and 5-fluorouracil in a mouse colon carcinoma model.
    Wu X; He C; Wu Y; Chen X
    Biomaterials; 2016 Jan; 75():148-162. PubMed ID: 26497429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
    Papadimitriou CA; Papakostas P; Karina M; Malettou L; Dimopoulos MA; Pentheroudakis G; Samantas E; Bamias A; Miliaras D; Basdanis G; Xiros N; Klouvas G; Bafaloukos D; Kafiri G; Papaspirou I; Pectasides D; Karanikiotis C; Economopoulos T; Efstratiou I; Korantzis I; Pisanidis N; Makatsoris T; Matsiakou F; Aravantinos G; Kalofonos HP; Fountzilas G
    BMC Med; 2011 Jan; 9():10. PubMed ID: 21281463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer.
    Zhao Y; Wang C; Goel A
    Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.
    Touil Y; Igoudjil W; Corvaisier M; Dessein AF; Vandomme J; Monté D; Stechly L; Skrypek N; Langlois C; Grard G; Millet G; Leteurtre E; Dumont P; Truant S; Pruvot FR; Hebbar M; Fan F; Ellis LM; Formstecher P; Van Seuningen I; Gespach C; Polakowska R; Huet G
    Clin Cancer Res; 2014 Feb; 20(4):837-46. PubMed ID: 24323901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canonical Wnt Pathway Is Involved in Chemoresistance and Cell Cycle Arrest Induction in Colon Cancer Cell Line Spheroids.
    Moreno-Londoño AP; Castañeda-Patlán MC; Sarabia-Sánchez MA; Macías-Silva M; Robles-Flores M
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
    Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
    Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line.
    Kjellström J; Kjellén E; Johnsson A
    Acta Oncol; 2005; 44(7):687-93. PubMed ID: 16227158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells.
    Pintova S; Planutis K; Planutiene M; Holcombe RF
    Anticancer Res; 2017 Apr; 37(4):1647-1653. PubMed ID: 28373425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
    Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
    Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of betulinic acid on anticancer drug-resistant colon cancer cells.
    Jung GR; Kim KJ; Choi CH; Lee TB; Han SI; Han HK; Lim SC
    Basic Clin Pharmacol Toxicol; 2007 Oct; 101(4):277-85. PubMed ID: 17845510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells.
    Sousa-Squiavinato ACM; Arregui Ramos DA; Wagner MS; Tessmann JW; de-Freitas-Junior JCM; Morgado-Díaz JA
    Eur J Pharmacol; 2022 Oct; 933():175253. PubMed ID: 36067803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.